Condition: Rectal Cancer · Sponsor: Peiyi Xie
This project aims to use multi-temporal, multi-parameter MRI features, blood biomarkers, and clinical indicators to accurately assess pseudoprogression following immunotherapy in rectal cancer.
This description comes directly from the study's public registry record.
Peiyi Xie
Always discuss trial participation with your own doctor first.
| Sixth affiliated hospital, Sun Yat-sen University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Xinyi People's hospital | Maoming, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07381322